Christian Dreger - PAREXEL International President

PRXL -- USA Stock  

null 88.06  0.04  0.0454%

  President
Dr. Christian Dreger, Ph.D., was appointed as Senior Vice President Parexel Access and Parexel Consulting of the Company. Dr. Dreger joins PAREXEL from Biogen where he served as Vice President and Head of Global Commercial Operations, Biosimilars, in Zug, Switzerland. Dr. Dreger has also held international commercial and sales positions of increasing responsibility with billiondollar PL and performance management responsibilities at Cubist Pharmaceuticals, AstraZeneca, ScheringPlough, and Roche Pharmaceuticals and Diagnostics. He started his career as a consultant with McKinsey Co. in Germany
  President Since 2016  MBA    
781 487-9900  http://www.parexel.com
Dreger holds an MBA and a Ph.D. from the University of Mannheim in Germany and St. Gallen, Switzerland, and an Executive MBA from Northwestern University Kellogg Graduate School of Management. He also holds an LLB from the University of Hagen in Germany and is a certified pharmaceutical advisor and board director from INSEAD, Fontainebleau, France.

Management Efficiency

The company has return on total asset (ROA) of 6.72 % which means that it generated profit of $6.72 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 16.93 % meaning that it created $16.93 on every $100 dollars invested by stockholders.
The company currently holds 671.5M in liabilities with Debt to Equity (D/E) ratio of 105.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PAREXEL International has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives

PRESIDENT Since

Jing LiSinovac Biotech Ltd
2016
James DillardPerrigo Company plc
2019
Kristin PeckZoetis
2018
Scott JamisonPerrigo Company plc
2011
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Jay MarkowitzRegeneron Pharmaceuticals
2017
John HendricksonPerrigo Company plc
2016
Douglas McCorkleRegeneron Pharmaceuticals
2007
Jatin ShahPerrigo Company plc
2005
Joseph LaRosaRegeneron Pharmaceuticals
2019
K RaoDr Reddys Laboratories Ltd
2016
Paul WeningerPerrigo Company plc
2015
M RamanaDr Reddys Laboratories Ltd
2018
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
J RamachandranDr Reddys Laboratories Ltd
2016
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Umang VohraDr Reddys Laboratories Ltd
2013
Samiran DasDr Reddys Laboratories Ltd
2016
Michael PariniVertex Pharmaceuticals Incorpor
2017
Ganadhish KamatDr Reddys Laboratories Ltd
2016

Entity Summary

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide. PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people.

PAREXEL International Leadership Team

Michelle Graham, Chief Human Resource Officer, Senior Vice President
Ulf Schneider, Chief Administrative Officer, Senior Vice President
Thomas Senderovitz, Senior Vice President - Clinical Research Services
Dana Callow, Presiding Independent Director
Emma Reeve, Interim CFO, Corporate Vice President Controller
Josef Rickenbach, Founder, Chairman and CEO
Patrick Fortune, Independent Director
Eduard Holdener, Independent Director
Simon Harford, CFO, Senior Vice President
Joshua Schultz, Senior Vice President-Worldwide Head of PAREXEL Access
Gadi Saarony, Senior Vice President - Clinical Research Services
Ellen Zane, Director, Member of Compensation Committee, Member of HR Committee, CEO of Tufts Medical Center and President of Tufts Medical Center
Christian Dreger, Senior Vice President - Parexel Access and Parexel Consulting
Xavier Flinois, President - Perceptive Informatics
Douglas Batt, Sr. VP, General Counsel and Secretary
Sybrand Pretorius, Senior Vice President Chief Scientific Officer
Maykin Ho, Director
Richard Love, Independent Director
Ronald Aldridge, Sr. Director, Investor Relations
Mark Goldberg, President COO
Roland Andersson, Senior Vice President - Clinical Research Services
Christopher Lindop, Independent Director
Ingo Bank, CFO and Sr. VP
David Godwin, Senior Vice President-Global Business

Stock Performance Indicators

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Currently Active Assets on Macroaxis

TWTR   
Purchased over 50 shares of
few hours ago
Traded for 1.0
MGTI   
Purchased over 50 shares of
few hours ago
Traded for 1.0
PVCT   
Purchased over 10K shares of
few hours ago
Traded for 1.0
BTSC   
Purchased over 10K shares of
few hours ago
Traded for 1.0
ALNY   
Purchased few shares of
few hours ago
Traded for 1.0
Additionally take a look at Your Equity Center. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Search macroaxis.com